Public Controversies

CVRx Faces Class Action Lawsuit Following DOJ Probe and Guidance Cut

· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

2 min read

Key takeawaysA securities class action lawsuit has been filed against CVRx, Inc. (Nasdaq: CVRX) following a significant decline in its share price. The litigation concerns investors who purchased company securities between July 25, 2023, and August 6, 2026.
CVRx Faces Class Action Lawsuit Following DOJ Probe and Guidance Cut

Original GlobeWire Daily editorial illustration — not an event photograph.

A securities class action lawsuit has been filed against CVRx, Inc. (Nasdaq: CVRX) following a significant decline in its share price. The litigation concerns investors who purchased company securities between July 25, 2023, and August 6, 2026.

Background of the Dispute

The lawsuit follows a disclosure made in a Form 10-Q filing on August 6, 2026. In this filing, the company revealed that it had received a civil investigative demand from the U.S. Department of Justice on May 14, 2026, regarding a potential False Claims Act probe. The inquiry focuses on allegations involving the marketing of the medical device Barostim, including potential kickbacks to healthcare providers and the submission of false information to government health programs.

On the same day, CVRx lowered its financial outlook, attributing the reduction to lower-than-expected productivity among its sales force. Following these disclosures, CVRx shares dropped from a closing price of $5.94 on August 6 to $2.39 on August 7, representing a single-session decline of approximately 60%.

Allegations

The complaint alleges that statements regarding the sustainability of Barostim revenue and the effectiveness of the company's sales force realignment were materially misleading during the class period. Plaintiffs contend that the stock price was artificially inflated by failing to disclose risks associated with alleged unlawful marketing practices and operational challenges.

Investor Information

  • Lead Plaintiff Deadline: January 8, 2027.
  • Class Period: July 25, 2023 – August 6, 2026.
  • Nature of Suit: Securities class action alleging false and misleading statements.

Investors who incurred losses during the specified period may be eligible to participate. Interested parties can review their potential eligibility by contacting legal counsel, such as Levi & Korsinsky, LLP, or by reviewing court filings to confirm the status of the case. Participation in a class action does not typically require individual testimony in court.

Share this article
Read the original source: CVRX Shareholder Alert: CVRx, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

AI-assisted reporting; source claims are attributed and have not been independently verified.

About the author

GlobeWire Daily Editorial Desk — AI-assisted news based on attributed published sources.

More to read